Order Article Reprints

Monti M, Morgagni P, Nanni O, Framarini M, Saragoni L, Marrelli D, Roviello F, Petrioli R, Fumagalli Romario U, Rimassa L, et al. Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers. 2020; 12(10):2790. https://doi.org/10.3390/cancers12102790

Monti, Manlio, Paolo Morgagni, Oriana Nanni, Massimo Framarini, Luca Saragoni, Daniele Marrelli, Franco Roviello, Roberto Petrioli, Uberto Fumagalli Romario, Lorenza Rimassa, and et al. 2020. "Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial" Cancers 12, no. 10: 2790. https://doi.org/10.3390/cancers12102790

Monti, M., Morgagni, P., Nanni, O., Framarini, M., Saragoni, L., Marrelli, D., Roviello, F., Petrioli, R., Fumagalli Romario, U., Rimassa, L., Bozzarelli, S., Donini, A., Graziosi, L., De Angelis, V., De Manzoni, G., Bencivenga, M., Mengardo, V., Parma, E., Milandri, C., ... Frassineti, G. L. (2020). Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers, 12(10), 2790. https://doi.org/10.3390/cancers12102790